Doing now what patients need next
Pioneering diagnostics and pharma to create a healthier future for everyone
:quality(90)/)
In the spotlight
Roche publishes its first quarter results for 2026
Roche reports 7% (CER) sales for the full year results in 2025. Commenting on the results, CEO Thomas Schinecker said: “2025 was a strong year for Roche, reflecting our continued focus on operational and R&D excellence.”
How we improved outcomes for patients around the world
With our combined strengths in Diagnostic and Pharmaceuticals, we worked to provide real and positive change for patients, the people they love and the professionals who care for them. Discover the highlights in our Annual Report.
Our two divisions are focusing jointly on three disease areas that will account for almost 50% of the global disease burden by 2035: cancer, cardiovascular-metabolic diseases and neurological diseases.
Investor information
We are Roche
We combine life-changing diagnostics and medicines to take on the toughest healthcare challenges, those that place the greatest strain on patients, families, communities, and health systems.
Guided by the experiences of patients, we are determined to prevent, stop and cure diseases so people can live healthier, longer lives.

Our mission in action
Read our stories
Shape the future of healthcare
Join our global team of innovators, scientists, and changemakers
:quality(90)/)



:quality(90)/)
:quality(90)/)
:quality(90)/)

:quality(90)/)
:quality(90)/)

:quality(90)/)